|
As of October 1, 2018, the AskIHB secure communication web portal for clinical assistance is no longer available. The Immunization Healthcare Branch will continue to provide 24/7 clinical support through the Immunization Healthcare Support Center at (877) GET-VACC (438- 8222), Option 1, or DSN 761-4245.
|
| Current Issues in Vaccines webinar |
This November 14 webinar will discuss the latest influenza vaccine updates, the impact of pneumococcal conjugate vaccine (PCV13), and the possible expanded recommendation for human papillomavirus (HPV) vaccine. |
November 5, 2018 |
| Notice of Precautionary Handling Instructions for Certain EpiPen Auto-Injectors |
A notice that some EpiPen® 0.3 mg and EpiPen Jr® 0.15 mg Auto-Injectors, and their authorized generic versions, may not easily slide out of their carrier tube, which could delay or potentially prevent use of the device during an emergency. |
November 5, 2018 |
Updates from October 2018 ACIP Meeting
|
This November 6 webinar will discuss updates from the October 2018 Advisory Committee on Immunization Practices (ACIP) meeting, including current U.S. vaccination recommendations for adults, adolescents, and children.
|
October 31, 2018 |
| MMQC-18-2500 Current Yellow Fever Vaccine Inventory - Suspense 10 November 2018 |
All immunization sites are to report their inventory of yellow fever vaccine, even if they have on-hand zero balance, by November 10, 2018. |
October 30, 2018 |
| Anthrax Infections and Anthrax Vaccine |
Information paper updated to remove information regarding the Anthrax Vaccine in Pregnancy Registry. |
October 26, 2018
|
|
When Pregnancy Is Discovered After Anthrax Vaccination
|
Information paper updated to reflect that new enrollment in the Anthrax Vaccine in Pregnancy registry has been discontinued. |
October 26, 2018
|
| Update: Influenza Activity — United States and Worldwide, May 20–October 13, 2018 |
In the United States, reported influenza activity was low in all regions, typical for this time of year. Fourteen influenza variant virus infections were reported in the U.S., and most were associated with exposure to swine.
|
October 26, 2018
|
Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
|
Vaccine-derived polioviruses (VDPVs) can circulate in settings of low population immunity or during outbreaks. After the 2016 synchronized switch from trivalent oral poliovirus vaccine (OPV) (types 1, 2, and 3) to bivalent OPV (types 1 and 3), new circulating VDPV outbreaks were detected in five countries.
|
October 26, 2018
|
|
Measles Outbreak in a Highly Vaccinated Population — Israel, July–August 2017
|
During July and August 2017, nine measles cases occurred among vaccinated Israeli soldiers. The primary patient had recently traveled to Europe. All other cases occurred in his direct contacts. All patients had mild illness; no tertiary cases occurred.
|
October 26, 2018
|
Japanese Encephalitis and Japanese Encephalitis Vaccine
|
A DHA-IHB information paper updated to include the recently licensed accelerated Japanese Encephalitis vaccination schedule for people at prolonged risk for infection. |
October 25, 2018
|
| ProQuad package insert |
The prescribing information for ProQuad measles-mumps-rubella-varicella (MMRV) vaccine has been updated to clarify some information from Post-Marketing Experience.
|
October 25, 2018
|
| Influenza Vaccine Product List and Age Groups 2018-19 |
An updated list to reflect the new FDA-licensed age range for Afluria influenza vaccine. |
October 24, 2018 |
| Summer may be gone, but West Nile Virus remains a threat |
Taking steps to prevent mosquito bites can be the best way to reduce risk of West Nile Virus infection and other mosquito-borne illnesses.
|
October 24, 2018 |
|
Mumps Outbreak in a Marshallese Community — Denver Metropolitan Area, Colorado, 2016–2017
|
An outbreak of 47 mumps cases occurred in the Denver metropolitan area, mostly among members of a Marshallese community. Public health response included early active surveillance, public education, and prompt implementation of MMR vaccination clinics.
|
October 23, 2018
|
|
Vaccination Coverage for Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2017–18 School Year
|
Immunization programs conduct annual kindergarten vaccination assessments to monitor school-entry vaccination coverage for all state-required vaccines. Median vaccination coverage was 94.3% for 2 doses of measles, mumps, and rubella vaccine; 95.1% for the state-required number of doses of diphtheria and tetanus toxoids and acellular pertussis vaccine; and 93.8% for 2 doses of varicella vaccine.
|
October 23, 2018
|
|
Vaccination Coverage Among Children Aged 19–35 Months — United States, 2017
|
The Advisory Committee on Immunization Practices recommends routine vaccination by age 24 months against 14 potentially serious illnesses. In 2017, coverage with most recommended vaccines among children aged 19–35 months remained stable and high but was lower in more rural areas and among uninsured or Medicaid-insured children.
|
October 23, 2018
|
|
Notes from the Field: Rubella Infection in an Unvaccinated Pregnant Woman — Johnson County, Kansas, December 2017
|
An unvaccinated patient tested positive for rubella infection while pregnant, after her unvaccinated brother returned home from a rubella-endemic part of the world. Rubella infection in pregnancy can result in miscarriage, stillbirth, or congenital rubella syndrome (CRS). The patient, under care for a high-risk pregnancy, eventually delivered a full-term, apparently normal, infant.
|
October 23, 2018
|
|
Varivax package insert
|
The prescribing information for Varivax chickenpox vaccine has been updated to clarify some information from Post-Marketing Experience.
|
October 23, 2018
|
| Pneumococcal Vaccines: Strategies to Increase Adult Immunization Rates |
This October 30, 2018 webinar will discuss the importance of pneumococcal vaccines in adults, with a focus on strategies for determining which pneumococcal vaccine to give to whom and when. |
October 22, 2018 |
| Afluria Quadrivalent package insert |
Updated prescribing information for Afluria quadrivalent influenza vaccine, to include the expansion of the age indication to everyone 6 months and older. |
October 18, 2018 |
| Smallpox Vaccine and Contact Transmission Avoidance |
This information paper describes precautions to be taken by household or other close contacts of those who recently received smallpox vaccine.
|
October 18, 2018
|
| Hepatitis B Vaccine Information Statement (VIS) |
Updates to add the available option of a 2-dose schedule. |
October 16, 2018
|
| Immunization Tool Kit 9th Edition (2018) |
The Immunization Tool Kit (ITK) is a practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. It is based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines. The printed version of the new ITK is underway, and will be announced when available.
|
October 16, 2018 |
| FDA Approval for Afluria Age Expansion |
The Food and Drug Administration (FDA) has extended the age indication for Afluria quadrivalent and trivalent influenza vaccine for use in persons ages 6 to 59 months. |
October 11, 2018 |
Gardasil 9 package insert
|
The human papillomavirus (HPV) vaccine has been approved by the FDA for use in women and men up to 45 years of age.
|
October 9, 2018
|
|
IXIARO package insert
|
The FDA has approved an alternate, compressed primary Japanese encephalitis vaccination schedule for those at prolonged high risk.
|
October 9, 2018
|
|
Menveo package insert
|
Updates information associated with altered immunocompetence in recipients of a certain blood-disorder treatment.
|
October 9, 2018 |